Skip to main content
SpringerLink
Log in

Biochemical Markers

  • Chapter
  • First Online:
Understanding Suicide

Abstract

Suicide is a complicated phenomenon related with the interaction of several neurobiological changes and psychosocial factors. The previous postmortem and clinical studies have explored neurobiological changes associated with suicide behavior. These suggest that decreased serotonin function and increased hypothalamic–pituitary–adrenal (HPA) axis are associated with suicide behavior. Serotonin dysfunction in individuals with suicidal behavior has been observed as decreased 5-hydroxyindoleacetic acid (5-HIAA) level in the cerebrospinal fluid, blunted prolactin response to fenfluramine challenge studies, and increased number of platelet serotonin 2A receptors. HPA axis dysfunction in those with suicidal behavior has been shown as increased cortisol level and non-suppression cortisol response to the dexamethasone suppression test. In addition, the reduction of cholesterol and BDNF levels in suicide has been observed, and they can be measured in blood, serum, or plasma. It is still a challenge to the field to find both promising and easily assessable neurobiological predictors of suicidal behavior.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Alvarez JC, Cremniter D, Gluck N, Quintin P, Leboyer M, Berlin I, Therond P, Spreux-Varoquaux O (2000) Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Res 95(2):103–108

    Article  CAS  PubMed  Google Scholar 

  • Arango V, Ernsberger P, Marzuk PM, Chen JS, Tierney H, Stanley M, Reis DJ, Mann JJ (1990) Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47(11):1038–1047

    Article  CAS  PubMed  Google Scholar 

  • Arango V, Underwood MD, Mann JJ (1996) Fewer pigmented locus coeruleus neurons in suicide victims: preliminary results. Biol Psychiatry 39(2):112–120

    Article  CAS  PubMed  Google Scholar 

  • Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S, Chen JJ, Mann JJ (2001) Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 25(6):892–903

    Article  CAS  Google Scholar 

  • Arato M, Banki CM, Bissette G, Nemeroff CB (1989) Elevated CSF CRF in suicide victims. Biol Psychiatry 25(3):355–359

    Article  CAS  PubMed  Google Scholar 

  • Arora RC, Meltzer HY (1989a) Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients. Life Sci 44(11):725–734

    Article  CAS  PubMed  Google Scholar 

  • Arora RC, Meltzer HY (1989b) Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 146(6):730–736

    Article  CAS  PubMed  Google Scholar 

  • Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J (1994) Brain 5-HT1A, 5-HT1D, and 5-HT2 receptors in suicide victims. Biol Psychiatry 35(7):457–463

    Article  CAS  PubMed  Google Scholar 

  • Asberg M (1997) Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann N Y Acad Sci 836:158–181

    Article  CAS  PubMed  Google Scholar 

  • Asberg M, Traskman L, Thoren P (1976) 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33(10):1193–1197

    Article  CAS  PubMed  Google Scholar 

  • Asellus P, Nordstrom P, Jokinen J (2010) Cholesterol and CSF 5-HIAA in attempted suicide. J Affect Disord 125(1–3):388–392

    Article  CAS  PubMed  Google Scholar 

  • Audenaert K, Van Laere K, Dumont F, Slegers G, Mertens J, van Heeringen C, Dierckx RA (2001) Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients. Eur J Nucl Med 28(2):175–182

    Article  CAS  PubMed  Google Scholar 

  • Autry AE, Monteggia LM (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 64(2):238–258

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Baek JH, Kang ES, Fava M, Mischoulon D, Nierenberg AA, Yu BH, Lee D, Jeon HJ (2014) Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 51:113–118

    Article  CAS  Google Scholar 

  • Banki CM, Arato M, Papp Z, Kurcz M (1984) Biochemical markers in suicidal patients. Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. J Affect Disord 6(3–4):341–350

    Article  CAS  PubMed  Google Scholar 

  • Barbacid M (1994) The Trk family of neurotrophin receptors. J Neurobiol 25(11):1386–1403

    Article  CAS  PubMed  Google Scholar 

  • Baumann B, Danos P, Diekmann S, Krell D, Bielau H, Geretsegger C, Wurthmann C, Bernstein HG, Bogerts B (1999) Tyrosine hydroxylase immunoreactivity in the locus coeruleus is reduced in depressed non-suicidal patients but normal in depressed suicide patients. Eur Arch Psychiatry Clin Neurosci 249(4):212–219

    Article  CAS  PubMed  Google Scholar 

  • Biegon A, Fieldust S (1992) Reduced tyrosine hydroxylase immunoreactivity in locus coeruleus of suicide victims. Synapse (New York, NY) 10(1):79–82

    Article  CAS  Google Scholar 

  • Biegon A, Weizman A, Karp L, Ram A, Tiano S, Wolff M (1987) Serotonin 5-HT2 receptor binding on blood platelets – a peripheral marker for depression? Life Sci 41(22):2485–2492

    Article  CAS  PubMed  Google Scholar 

  • Black DW, Monahan PO, Winokur G (2002) The relationship between DST results and suicidal behavior. Ann Clin Psychiatry: Off J Am Acad Clin Psychiatr 14(2):83–88

    Article  Google Scholar 

  • Boldrini M, Underwood MD, Mann JJ, Arango V (2005) More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res 1041(1):19–28

    Article  CAS  PubMed  Google Scholar 

  • Bonkale WL, Turecki G, Austin MC (2006) Increased tryptophan hydroxylase immunoreactivity in the dorsal raphe nucleus of alcohol-dependent, depressed suicide subjects is restricted to the dorsal subnucleus. Synapse (New York, NY) 60(1):81–85

    Article  CAS  Google Scholar 

  • Callado LF, Meana JJ, Grijalba B, Pazos A, Sastre M, Garcia-Sevilla JA (1998) Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims. J Neurochem 70(3):1114–1123

    Article  CAS  PubMed  Google Scholar 

  • Castren E, Voikar V, Rantamaki T (2007) Role of neurotrophic factors in depression. Curr Opin Pharmacol 7(1):18–21

    Article  CAS  PubMed  Google Scholar 

  • Cleare AJ, Murray RM, O’Keane V (1996) Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 14(5):349–354

    Article  CAS  Google Scholar 

  • Correa H, Duval F, Mokrani M, Bailey P, Tremeau F, Staner L, Diep TS, Hode Y, Crocq MA, Macher JP (2000) Prolactin response to D-fenfluramine and suicidal behavior in depressed patients. Psychiatry Res 93(3):189–199

    Article  CAS  PubMed  Google Scholar 

  • Correa H, Duval F, Mokrani MC, Bailey P, Tremeau F, Staner L, Diep TS, Crocq MA, Macher JP (2002) Serotonergic function and suicidal behavior in schizophrenia. Schizophr Res 56(1–2):75–85

    Article  PubMed  Google Scholar 

  • Coryell W, Schlesser M (2001) The dexamethasone suppression test and suicide prediction. Am J Psychiatry 158(5):748–753

    Article  CAS  PubMed  Google Scholar 

  • Coryell W, Young E, Carroll B (2006) Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder. Psychiatry Res 142(1):99–104

    Article  CAS  PubMed  Google Scholar 

  • Cote F, Fligny C, Fromes Y, Mallet J, Vodjdani G (2004) Recent advances in understanding serotonin regulation of cardiovascular function. Trends Mol Med 10(5):232–238

    Article  CAS  PubMed  Google Scholar 

  • D’Ambrosio V, Salvi V, Bogetto F, Maina G (2012) Serum lipids, metabolic syndrome and lifetime suicide attempts in patients with bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 37(1):136–140

    Article  CAS  Google Scholar 

  • Dawood T, Anderson J, Barton D, Lambert E, Esler M, Hotchkin E, Haikerwal D, Kaye D, Lambert G (2007) Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness. Mol Psychiatry 12(11):981–983

    Article  CAS  PubMed  Google Scholar 

  • de Leon J, Mallory P, Maw L, Susce MT, Perez-Rodriguez MM, Baca-Garcia E (2011) Lack of replication of the association of low serum cholesterol and attempted suicide in another country raises more questions. Ann Clin Psychiatry: Off J Am Acad Clin Psychiatr 23(3):163–170

    Google Scholar 

  • De Paermentier F, Cheetham SC, Crompton MR, Katona CL, Horton RW (1990) Brain beta-adrenoceptor binding sites in antidepressant-free depressed suicide victims. Brain Res 525(1):71–77

    Article  PubMed  Google Scholar 

  • De Paermentier F, Crompton MR, Katona CL, Horton RW (1992) beta-adrenoceptors in brain and pineal from depressed suicide victims. Pharmacol Toxicol 71(Suppl 1):86–95

    Article  PubMed  Google Scholar 

  • Deveci A, Aydemir O, Taskin O, Taneli F, Esen-Danaci A (2007) Serum BDNF levels in suicide attempters related to psychosocial stressors: a comparative study with depression. Neuropsychobiology 56(2–3):93–97

    Article  PubMed  Google Scholar 

  • Diaz-Sastre C, Baca-Garcia E, Perez-Rodriguez MM, Garcia-Resa E, Ceverino A, Saiz-Ruiz J, Oquendo MA, de Leon J (2007) Low plasma cholesterol levels in suicidal males: a gender- and body mass index-matched case-control study of suicide attempters and nonattempters. Prog Neuro-Psychopharmacol Biol Psychiatry 31(4):901–905

    Article  CAS  Google Scholar 

  • Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54(7):597–606

    Article  CAS  PubMed  Google Scholar 

  • Duval F, Mokrani MC, Correa H, Bailey P, Valdebenito M, Monreal J, Crocq MA, Macher JP (2001) Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Psychoneuroendocrinology 26(5):521–537

    Article  CAS  PubMed  Google Scholar 

  • Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN (2003) Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60(8):804–815

    Article  CAS  PubMed  Google Scholar 

  • Dwivedi Y, Rizavi HS, Pandey GN (2006) Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Neuroscience 139(3):1017–1029

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dwivedi Y, Rizavi HS, Zhang H, Mondal AC, Roberts RC, Conley RR, Pandey GN (2009) Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide. Biol Psychiatry 65(4):319–328

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ehnvall A, Sjogren M, Zachrisson OC, Agren H (2004) HPA axis activation determined by the CRH challenge test in patients with few versus multiple episodes of treatment-refractory depression. Eur Arch Psychiatry Clin Neurosci 254(6):349–355

    Article  PubMed  Google Scholar 

  • Eide FF, Vining ER, Eide BL, Zang K, Wang XY, Reichardt LF (1996) Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J Neurosci: Off J Soc Neurosci 16(10):3123–3129

    CAS  Google Scholar 

  • Ellison LF, Morrison HI (2001) Low serum cholesterol concentration and risk of suicide. Epidemiology (Cambridge, Mass) 12(2):168–172

    Article  CAS  Google Scholar 

  • Engstrom G, Alling C, Blennow K, Regnell G, Traskman-Bendz L (1999) Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 9(5):399–405

    Article  CAS  Google Scholar 

  • Ernst C, Mechawar N, Turecki G (2009) Suicide neurobiology. Prog Neurobiol 89(4):315–333

    Article  CAS  PubMed  Google Scholar 

  • Escriba PV, Ozaita A, Garcia-Sevilla JA (2004) Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 29(8):1512–1521

    Article  CAS  Google Scholar 

  • Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V et al (1987) Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 317(20):1237–1245

    Article  CAS  PubMed  Google Scholar 

  • Galfalvy H, Currier D, Oquendo MA, Sullivan G, Huang YY, John Mann J (2009) Lower CSF MHPG predicts short-term risk for suicide attempt. Int J Neuropsychopharmacol: Off Sci J Coll Int Neuropsychopharmacol (CINP) 12(10):1327–1335

    Article  CAS  Google Scholar 

  • Garcia-Sevilla JA, Escriba PV, Ozaita A, La Harpe R, Walzer C, Eytan A, Guimon J (1999) Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides. J Neurochem 72(1):282–291

    Article  CAS  PubMed  Google Scholar 

  • Garvey MJ, Hollon SD, Tuason VB (1994) Relationship between 3-methoxy-4-hydroxyphenylglycol and suicide. Neuropsychobiology 29(3):112–116

    Article  CAS  PubMed  Google Scholar 

  • Gershon MD, Tack J (2007) The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 132(1):397–414

    Article  CAS  PubMed  Google Scholar 

  • Gonzalez AM, Pascual J, Meana JJ, Barturen F, del Arco C, Pazos A, Garcia-Sevilla JA (1994) Autoradiographic demonstration of increased alpha 2-adrenoceptor agonist binding sites in the hippocampus and frontal cortex of depressed suicide victims. J Neurochem 63(1):256–265

    Article  CAS  PubMed  Google Scholar 

  • Gos T, Krell D, Bielau H, Brisch R, Trubner K, Steiner J, Bernstein HG, Jankowski Z, Bogerts B (2008) Tyrosine hydroxylase immunoreactivity in the locus coeruleus is elevated in violent suicidal depressive patients. Eur Arch Psychiatry Clin Neurosci 258(8):513–520

    Article  PubMed  Google Scholar 

  • Heron DS, Shinitzky M, Hershkowitz M, Samuel D (1980) Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci U S A 77(12):7463–7467

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hrdina PD, Bakish D, Chudzik J, Ravindran A, Lapierre YD (1995) Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. J Psychiatry Neurosci: JPN 20(1):11–19

    CAS  PubMed  PubMed Central  Google Scholar 

  • Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677–736

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jokinen J, Nordstrom P (2008) HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients. Psychoneuroendocrinology 33(10):1387–1393

    Article  CAS  PubMed  Google Scholar 

  • Jokinen J, Nordstrom P (2009) HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients. J Affect Disord 116(1–2):117–120

    Article  CAS  PubMed  Google Scholar 

  • Jokinen J, Carlborg A, Martensson B, Forslund K, Nordstrom AL, Nordstrom P (2007) DST non-suppression predicts suicide after attempted suicide. Psychiatry Res 150(3):297–303

    Article  PubMed  Google Scholar 

  • Jokinen J, Nordstrom AL, Nordstrom P (2008) ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide. J Affect Disord 106(1–2):145–152

    Article  CAS  PubMed  Google Scholar 

  • Jokinen J, Nordstrom AL, Nordstrom P (2009) CSF 5-HIAA and DST non-suppression – orthogonal biologic risk factors for suicide in male mood disorder inpatients. Psychiatry Res 165(1–2):96–102

    Article  CAS  PubMed  Google Scholar 

  • Jokinen J, Ouda J, Nordstrom P (2010) Noradrenergic function and HPA axis dysregulation in suicidal behaviour. Psychoneuroendocrinology 35(10):1536–1542

    Article  CAS  PubMed  Google Scholar 

  • Karege F, Schwald M, Cisse M (2002) Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 328(3):261–264

    Article  CAS  PubMed  Google Scholar 

  • Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R (2005) Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain research. Mol Brain Res 136(1–2):29–37

    Article  CAS  PubMed  Google Scholar 

  • Keilp JG, Oquendo MA, Stanley BH, Burke AK, Cooper TB, Malone KM, Mann JJ (2010) Future suicide attempt and responses to serotonergic challenge. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 35(5):1063–1072

    Article  CAS  Google Scholar 

  • Kim YK, Myint AM (2004) Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. J Affect Disord 81(2):161–166

    Article  CAS  PubMed  Google Scholar 

  • Kim YK, Lee HJ, Kim JY, Yoon DK, Choi SH, Lee MS (2002) Low serum cholesterol is correlated to suicidality in a Korean sample. Acta Psychiatr Scand 105(2):141–148

    Article  PubMed  Google Scholar 

  • Kim YK, Lee HP, Won SD, Park EY, Lee HY, Lee BH, Lee SW, Yoon D, Han C, Kim DJ, Choi SH (2007) Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 31(1):78–85

    Article  CAS  Google Scholar 

  • Kovacic Z, Henigsberg N, Pivac N, Nedic G, Borovecki A (2008) Platelet serotonin concentration and suicidal behavior in combat related posttraumatic stress disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 32(2):544–551

    Article  CAS  Google Scholar 

  • Kunugi H, Takei N, Aoki H, Nanko S (1997) Low serum cholesterol in suicide attempters. Biol Psychiatry 41(2):196–200

    Article  CAS  PubMed  Google Scholar 

  • Kunugi H, Urushibara T, Nanko S (2004) Combined DEX/CRH test among Japanese patients with major depression. J Psychiatr Res 38(2):123–128

    Article  PubMed  Google Scholar 

  • Kvetnansky R, Sabban EL, Palkovits M (2009) Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev 89(2):535–606

    Article  CAS  PubMed  Google Scholar 

  • Lauterbach E, Brunner J, Hawellek B, Lewitzka U, Ising M, Bondy B, Rao ML, Frahnert C, Rujescu D, Muller-Oerlinghausen B, Schley J, Heuser I, Maier W, Hohagen F, Felber W, Bronisch T (2006) Platelet 5-HT2A receptor binding and tryptophan availability in depression are not associated with recent history of suicide attempts but with personality traits characteristic for suicidal behavior. J Affect Disord 91(1):57–62

    Article  CAS  PubMed  Google Scholar 

  • Lee HJ, Kim YK (2003) Serum lipid levels and suicide attempts. Acta Psychiatr Scand 108(3):215–221

    Article  CAS  PubMed  Google Scholar 

  • Lee BH, Kim YK (2009) Reduced platelet BDNF level in patients with major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 33(5):849–853

    Article  CAS  Google Scholar 

  • Lee BH, Kim YK (2011) Potential peripheral biological predictors of suicidal behavior in major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 35(4):842–847

    Article  CAS  Google Scholar 

  • Lee BH, Kim H, Park SH, Kim YK (2007) Decreased plasma BDNF level in depressive patients. J Affect Disord 101(1–3):239–244

    Article  CAS  PubMed  Google Scholar 

  • Lesch KP, Araragi N, Waider J, van den Hove D, Gutknecht L (2012) Targeting brain serotonin synthesis: insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviour. Philos Trans R Soc Lond Ser B Biol Sci 367(1601):2426–2443

    Article  CAS  Google Scholar 

  • Lessmann V, Gottmann K, Malcangio M (2003) Neurotrophin secretion: current facts and future prospects. Prog Neurobiol 69(5):341–374

    Article  CAS  PubMed  Google Scholar 

  • Lester D (1995) The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry 28(2):45–50

    Article  CAS  PubMed  Google Scholar 

  • Leyton M, Paquette V, Gravel P, Rosa-Neto P, Weston F, Diksic M, Benkelfat C (2006) alpha-[11C]Methyl-L-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 16(3):220–223

    Article  CAS  Google Scholar 

  • Lindqvist D, Isaksson A, Traskman-Bendz L, Brundin L (2008) Salivary cortisol and suicidal behavior – a follow-up study. Psychoneuroendocrinology 33(8):1061–1068

    Article  CAS  PubMed  Google Scholar 

  • Lindstrom MB, Ryding E, Bosson P, Ahnlide JA, Rosen I, Traskman-Bendz L (2004) Impulsivity related to brain serotonin transporter binding capacity in suicide attempters. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 14(4):295–300

    Article  CAS  Google Scholar 

  • Lonnqvist JK, Henriksson MM, Isometsa ET, Marttunen MJ, Heikkinen ME, Aro HM, Kuoppasalmi KI (1995) Mental disorders and suicide prevention. Psychiatry Clin Neurosci 49(Suppl 1):S111–S116

    Article  PubMed  Google Scholar 

  • Lopez JF, Palkovits M, Arato M, Mansour A, Akil H, Watson SJ (1992) Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology 56(4):491–501

    Article  CAS  PubMed  Google Scholar 

  • Malone KM, Corbitt EM, Li S, Mann JJ (1996) Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry: J Ment Sci 168(3):324–329

    Article  CAS  Google Scholar 

  • Mann JJ (2002) A current perspective of suicide and attempted suicide. Ann Intern Med 136(4):302–311

    Article  PubMed  Google Scholar 

  • Mann JJ, Stanley M, McBride PA, McEwen BS (1986) Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43(10):954–959

    Article  CAS  PubMed  Google Scholar 

  • Mann JJ, McBride PA, Anderson GM, Mieczkowski TA (1992) Platelet and whole blood serotonin content in depressed inpatients: correlations with acute and life-time psychopathology. Biol Psychiatry 32(3):243–257

    Article  CAS  PubMed  Google Scholar 

  • Mann JJ, McBride PA, Malone KM, DeMeo M, Keilp J (1995) Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 13(1):53–64

    Article  CAS  Google Scholar 

  • Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, Dwork AJ, Arango V (2000) A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57(8):729–738

    Article  CAS  PubMed  Google Scholar 

  • Mann JJ, Currier D, Stanley B, Oquendo MA, Amsel LV, Ellis SP (2006) Can biological tests assist prediction of suicide in mood disorders? Int J Neuropsychopharmacol: Off Sci J Coll Int Neuropsychopharmacol (CINP) 9(4):465–474

    Article  Google Scholar 

  • Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A, Pfrieger FW (2001) CNS synaptogenesis promoted by glia-derived cholesterol. Science (New York, NY) 294(5545):1354–1357

    Article  CAS  Google Scholar 

  • McGowan PO, Sasaki A, D’Alessio AC, Dymov S, Labonte B, Szyf M, Turecki G, Meaney MJ (2009) Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12(3):342–348

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Meana JJ, Garcia-Sevilla JA (1987) Increased alpha 2-adrenoceptor density in the frontal cortex of depressed suicide victims. J Neural Trans (Vienna, Austria: 1996) 70(3–4):377–381

    Article  CAS  Google Scholar 

  • Meana JJ, Barturen F, Garcia-Sevilla JA (1992) Alpha 2-adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression. Biol Psychiatry 31(5):471–490

    Article  CAS  PubMed  Google Scholar 

  • Meldolesi J, Sciorati C, Clementi E (2000) The p75 receptor: first insights into the transduction mechanisms leading to either cell death or survival. Trends Pharmacol Sci 21(7):242–243

    Article  CAS  PubMed  Google Scholar 

  • Merali Z, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Anisman H (2004) Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci: Off J Soc Neurosci 24(6):1478–1485

    Article  CAS  Google Scholar 

  • Merali Z, Kent P, Du L, Hrdina P, Palkovits M, Faludi G, Poulter MO, Bedard T, Anisman H (2006) Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects. Biol Psychiatry 59(7):594–602

    Article  CAS  PubMed  Google Scholar 

  • Middlemas DS, Lindberg RA, Hunter T (1991) trkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors. Mol Cell Biol 11(1):143–153

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mitchell PB, Smythe GA (1992) Elevated cortisol concentrations and the diminished prolactin response to fenfluramine. Am J Psychiatry 149(6):851–852

    CAS  PubMed  Google Scholar 

  • Muldoon MF, Manuck SB, Matthews KA (1990) Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 301:309–314

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Muldoon MF, Manuck SB, Mendelsohn AB, Kaplan JR, Belle SH (2001) Cholesterol reduction and non-illness mortality: meta-analysis of randomised clinical trials. BMJ 322(7277):11–15

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Muller-Oerlinghausen B, Roggenbach J, Franke L (2004) Serotonergic platelet markers of suicidal behavior – do they really exist? J Affect Disord 79(1–3):13–24

    Article  CAS  PubMed  Google Scholar 

  • Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M (1988) Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 45(6):577–579

    Article  CAS  PubMed  Google Scholar 

  • Nordstrom P, Samuelsson M, Asberg M, Traskman-Bendz L, Aberg-Wistedt A, Nordin C, Bertilsson L (1994) CSF 5-HIAA predicts suicide risk after attempted suicide. Suicide Life Threat Behav 24(1):1–9

    CAS  PubMed  Google Scholar 

  • Numakawa T, Suzuki S, Kumamaru E, Adachi N, Richards M, Kunugi H (2010) BDNF function and intracellular signaling in neurons. Histol Histopathol 25(2):237–258

    CAS  PubMed  Google Scholar 

  • O’Keane V, Dinan TG (1991) Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. Am J Psychiatry 148(8):1009–1015

    Article  PubMed  Google Scholar 

  • Oldehinkel AJ, van den Berg MD, Flentge F, Bouhuys AL, ter Horst GJ, Ormel J (2001) Urinary free cortisol excretion in elderly persons with minor and major depression. Psychiatry Res 104(1):39–47

    Article  CAS  PubMed  Google Scholar 

  • Olie E, Picot MC, Guillaume S, Abbar M, Courtet P (2011) Measurement of total serum cholesterol in the evaluation of suicidal risk. J Affect Disord 133(1–2):234–238

    Article  CAS  PubMed  Google Scholar 

  • Oquendo MA, Placidi GP, Malone KM, Campbell C, Keilp J, Brodsky B, Kegeles LS, Cooper TB, Parsey RV, van Heertum RL, Mann JJ (2003) Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry 60(1):14–22

    Article  PubMed  Google Scholar 

  • Ordway GA (1997) Pathophysiology of the locus coeruleus in suicide. Ann N Y Acad Sci 836:233–252

    Article  CAS  PubMed  Google Scholar 

  • Ordway GA, Smith KS, Haycock JW (1994) Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. J Neurochem 62(2):680–685

    Article  CAS  PubMed  Google Scholar 

  • Owens MJ, Nemeroff CB (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43(4):425–473

    CAS  PubMed  Google Scholar 

  • Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37(12):1553–1561

    Article  CAS  PubMed  Google Scholar 

  • Pandey GN, Dwivedi Y (2007) Noradrenergic function in suicide. Arch Suicide Res: Off J Int Acad Suicide Res 11(3):235–246

    Article  Google Scholar 

  • Pandey GN, Dwivedi Y (2010) What can post-mortem studies tell us about the pathoetiology of suicide? Future Neurol 5(5):701–720

    Article  PubMed  PubMed Central  Google Scholar 

  • Pandey GN, Pandey SC, Janicak PG, Marks RC, Davis JM (1990) Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry 28(3):215–222

    Article  CAS  PubMed  Google Scholar 

  • Pandey GN, Pandey SC, Dwivedi Y, Sharma RP, Janicak PG, Davis JM (1995) Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior. Am J Psychiatry 152(6):850–855

    Article  CAS  PubMed  Google Scholar 

  • Pandey GN, Dwivedi Y, Rizavi HS, Ren X, Pandey SC, Pesold C, Roberts RC, Conley RR, Tamminga CA (2002) Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 159(3):419–429

    Article  PubMed  Google Scholar 

  • Pandey GN, Ren X, Rizavi HS, Conley RR, Roberts RC, Dwivedi Y (2008) Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. Int J Neuropsychopharmacol: Off Sci J Coll Int Neuropsychopharmacol (CINP) 11(8):1047–1061

    Article  CAS  Google Scholar 

  • Papassotiropoulos A, Hawellek B, Frahnert C, Rao GS, Rao ML (1999) The risk of acute suicidality in psychiatric inpatients increases with low plasma cholesterol. Pharmacopsychiatry 32(1):1–4

    Article  CAS  PubMed  Google Scholar 

  • Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, Fuchs B, Ernst G, Holsboer F, Binder EB (2005) Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biol Psychiatry 57(4):336–342

    Article  CAS  PubMed  Google Scholar 

  • Pfrieger FW (2003) Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci: CMLS 60(6):1158–1171

    CAS  PubMed  Google Scholar 

  • Placidi GP, Oquendo MA, Malone KM, Huang YY, Ellis SP, Mann JJ (2001) Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels. Biol Psychiatry 50(10):783–791

    Article  CAS  PubMed  Google Scholar 

  • Pompili M, Innamorati M, Lester D, Girardi P, Tatarelli R (2010a) Nearly lethal resuscitated suicide attempters have no low serum levels of cholesterol and triglycerides. Psychol Rep 106(3):785–790

    Article  PubMed  Google Scholar 

  • Pompili M, Serafini G, Innamorati M, Moller-Leimkuhler AM, Giupponi G, Girardi P, Tatarelli R, Lester D (2010b) The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention. Eur Arch Psychiatry Clin Neurosci 260(8):583–600

    Article  PubMed  Google Scholar 

  • Prochazka H, Sjogren M, Agren H (2000) Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group. J Affect Disord 57(1–3):201–208

    Article  CAS  PubMed  Google Scholar 

  • Purselle DC, Nemeroff CB (2003) Serotonin transporter: a potential substrate in the biology of suicide. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 28(4):613–619

    Article  CAS  Google Scholar 

  • Quattrone A, Tedeschi G, Aguglia U, Scopacasa F, Direnzo GF, Annunziato L (1983) Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine. Br J Clin Pharmacol 16(5):471–475

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rao ML, Hawellek B, Papassotiropoulos A, Deister A, Frahnert C (1998) Upregulation of the platelet Serotonin2A receptor and low blood serotonin in suicidal psychiatric patients. Neuropsychobiology 38(2):84–89

    Article  CAS  PubMed  Google Scholar 

  • Reul JM, de Kloet ER (1985) Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117(6):2505–2511

    Article  CAS  PubMed  Google Scholar 

  • Ringo DL, Lindley SE, Faull KF, Faustman WO (1994) Cholesterol and serotonin: seeking a possible link between blood cholesterol and CSF 5-HIAA. Biol Psychiatry 35(12):957–959

    Article  CAS  PubMed  Google Scholar 

  • Roggenbach J, Muller-Oerlinghausen B, Franke L, Uebelhack R, Blank S, Ahrens B (2007) Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects. J Neural Trans (Vienna, Austria: 1996) 114(4):479–487

    Article  CAS  Google Scholar 

  • Roy A, Ninan P, Mazonson A, Pickar D, Van Kammen D, Linnoila M, Paul SM (1985) CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide. Psychol Med 15(2):335–340

    Article  CAS  PubMed  Google Scholar 

  • Ryding E, Ahnlide JA, Lindstrom M, Rosen I, Traskman-Bendz L (2006) Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy. Psychiatry Res 148(2–3):195–203

    Article  CAS  PubMed  Google Scholar 

  • Samuelsson M, Jokinen J, Nordstrom AL, Nordstrom P (2006) CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters. Acta Psychiatr Scand 113(1):44–47

    Article  CAS  PubMed  Google Scholar 

  • Shelton RC, Sanders-Bush E, Manier DH, Lewis DA (2009) Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience 158(4):1406–1415

    Article  CAS  PubMed  Google Scholar 

  • Sher L, Oquendo MA, Li S, Huang YY, Grunebaum MF, Burke AK, Malone KM, Mann JJ (2003) Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 28(9):1712–1719

    Article  CAS  Google Scholar 

  • Sher L, Carballo JJ, Grunebaum MF, Burke AK, Zalsman G, Huang YY, Mann JJ, Oquendo MA (2006) A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Bipolar Disord 8(5 Pt 2):543–550

    Article  CAS  PubMed  Google Scholar 

  • Sher L, Oquendo MA, Grunebaum MF, Burke AK, Huang YY, Mann JJ (2007) CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 17(1):12–15

    Article  CAS  Google Scholar 

  • Soloff PH, Kelly TM, Strotmeyer SJ, Malone KM, Mann JJ (2003) Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Psychiatry Res 119(1–2):11–24

    Article  CAS  PubMed  Google Scholar 

  • Stockmeier CA, Dilley GE, Shapiro LA, Overholser JC, Thompson PA, Meltzer HY (1997) Serotonin receptors in suicide victims with major depression. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 16(2):162–173

    Article  CAS  Google Scholar 

  • Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G (1998) Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci: Off J Soc Neurosci 18(18):7394–7401

    CAS  Google Scholar 

  • Stockmeier CA, Howley E, Shi X, Sobanska A, Clarke G, Friedman L, Rajkowska G (2009) Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder. J Psychiatr Res 43(10):887–894

    Article  PubMed  PubMed Central  Google Scholar 

  • Sunnqvist C, Westrin A, Traskman-Bendz L (2008) Suicide attempters: biological stress markers and adverse life events. Eur Arch Psychiatry Clin Neurosci 258(8):456–462

    Article  PubMed  Google Scholar 

  • Traskman L, Asberg M, Bertilsson L, Sjostrand L (1981) Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry 38(6):631–636

    Article  CAS  PubMed  Google Scholar 

  • Träskman-Bendz L, Alling C, Oreland L, RegnĂ©ll G, Vinge E, Ohman R (1992) Prediction of suicidal behavior from biologic tests. J Clin Psychopharmacol 12(2 Suppl):21S–26S

    PubMed  Google Scholar 

  • Traskman-Bendz L, Ekman R, Regnell G, Ohman R (1992) HPA-related CSF neuropeptides in suicide attempters. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 2(2):99–106

    Article  CAS  Google Scholar 

  • Underwood MD, Khaibulina AA, Ellis SP, Moran A, Rice PM, Mann JJ, Arango V (1999) Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims. Biol Psychiatry 46(4):473–483

    Article  CAS  PubMed  Google Scholar 

  • Underwood MD, Mann JJ, Arango V (2004) Serotonergic and noradrenergic neurobiology of alcoholic suicide. Alcohol Clin Exp Res 28(5 Suppl):57S–69S

    Article  CAS  PubMed  Google Scholar 

  • van Heeringen K, Audenaert K, Van de Wiele L, Verstraete A (2000) Cortisol in violent suicidal behaviour: association with personality and monoaminergic activity. J Affect Disord 60(3):181–189

    Article  PubMed  Google Scholar 

  • van Heeringen C, Audenaert K, Van Laere K, Dumont F, Slegers G, Mertens J, Dierckx RA (2003) Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. J Affect Disord 74(2):149–158

    Article  PubMed  CAS  Google Scholar 

  • van Heeringen C, Bijttebier S, Godfrin K (2011) Suicidal brains: a review of functional and structural brain studies in association with suicidal behaviour. Neurosci Biobehav Rev 35(3):688–698

    Article  PubMed  Google Scholar 

  • Vevera J, Zukov I, Morcinek T, Papezova H (2003) Cholesterol concentrations in violent and non-violent women suicide attempters. Eur Psychiatry:J Assoc Eur Psychiatr 18(1):23–27

    Article  CAS  Google Scholar 

  • Vuksan-Cusa B, Marcinko D, Nad S, Jakovljevic M (2009) Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts. Prog Neuro-Psychopharmacol Biol Psychiatry 33(1):109–112

    Article  CAS  Google Scholar 

  • Watson S, Gallagher P, Del-Estal D, Hearn A, Ferrier IN, Young AH (2002) Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychol Med 32(6):1021–1028

    Article  CAS  PubMed  Google Scholar 

  • Westrin A, Ekman R, Regnell G, Traskman-Bendz L (2001) A follow up study of suicide attempters: increase of CSF-somatostatin but no change in CSF-CRH. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol 11(2):135–143

    Article  CAS  Google Scholar 

  • Yerevanian BI, Feusner JD, Koek RJ, Mintz J (2004) The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. J Affect Disord 83(2–3):103–108

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Seoul Metropolitan Eunpyeong Hospital, 90, Baengyeonsan-ro, Eunpyeong-gu, Seoul, 122-913, Republic of Korea

    Bun-Hee Lee

  2. Department of Psychiatry, College of Medicine, Korea University Ansan Hospital, 516, Gojan-dong, Ansan, Kyunggi Province, 425-707, Republic of Korea

    Yong-Ku Kim

Authors
  1. Bun-Hee Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yong-Ku Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yong-Ku Kim .

Editor information

Editors and Affiliations

  1. Academic Hospital of Montpellier, University of Montpellier, Montpellier, France

    Philippe Courtet

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Lee, BH., Kim, YK. (2016). Biochemical Markers. In: Courtet, P. (eds) Understanding Suicide. Springer, Cham. https://doi.org/10.1007/978-3-319-26282-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26282-6_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26280-2

  • Online ISBN: 978-3-319-26282-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation